The ORAOV1 Polyclonal Antibody (PAC021908) is a valuable tool for researchers studying the ORAOV1 protein, a key regulator in oral cancer progression. This antibody, produced in rabbits, demonstrates high reactivity with human samples and is validated for use in Western blot applications. By specifically binding to the ORAOV1 protein, this antibody enables accurate detection and analysis in various cell types, making it an essential component for studies in oral cancer research.ORAOV1, also known as oral cancer overexpressed 1, plays a crucial role in the development and progression of oral cancer by promoting cell proliferation and inhibiting cell apoptosis.
Understanding the function and regulation of ORAOV1 is essential for identifying potential therapeutic targets and strategies for the treatment of oral cancer. With its ability to specifically target the ORAOV1 protein, this antibody provides researchers with a precise tool for investigating the mechanisms underlying oral cancer development and progression.
Antibody Name:
ORAOV1 Antibody (PACO21908)
Antibody SKU:
PACO21908
Size:
100ul
Host Species:
Rabbit
Tested Applications:
ELISA, WB
Recommended Dilutions:
ELISA:1:2000-1:10000, WB:1:500-1:3000
Species Reactivity:
Human
Immunogen:
Synthesized peptide derived from internal of human ORAV1.
Form:
Liquid
Storage Buffer:
Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Purification Method:
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen
Clonality:
Polyclonal
Conjugate:
Non-conjugated
Western blot analysis of extracts from 293 cells and HeLa cells, using ORAV1 antibody.
Synonyms:
Oral cancer overexpressed protein 1; Tumor amplified and overexpressed sequence 1; ORAOV1; TAOS1;
UniProt Protein Function:
ORAOV1: Belongs to the ORAOV1 family.Protein type: Unknown functionChromosomal Location of Human Ortholog: 11q13.3Biological Process: ribosomal large subunit biogenesis and assembly
